Respiratory Clinical Trials

Our respiratory system is our direct connection to the world, providing every cell in our body with the oxygen it needs to function. However, for those living with chronic lung conditions, every breath can feel like a challenge. Respiratory Clinical Trials are essential for developing next-generation inhalers, biologics, and therapies that aim to reduce inflammation, clear airways, and prevent long-term lung damage.

Pulmonary research focuses on the health of the lungs and the complex network of airways. Modern studies are shifting away from simply managing symptoms and moving toward “precision pulmonology,” which seeks to identify the specific biological triggers behind a patient’s breathing difficulties to provide more effective, personalized care.

Respiratory conditions frequently studied for medical research include:

• Asthma: Researching new biologics and long-acting inhalers for better daily control.

• COPD (Chronic Obstructive Pulmonary Disease): Testing therapies to reduce “flare-ups” and improve lung function.

• Chronic Cough: Investigating treatments that target the nerve pathways responsible for persistent coughing.

• Cystic Fibrosis (CF): Researching genetic-based therapies to improve mucus clearance and lung health.

• Idiopathic Pulmonary Fibrosis (IPF): Testing medications designed to slow or stop the scarring of lung tissue.

• Bronchiectasis: Exploring new ways to manage chronic airway inflammation and prevent infections.

• Sleep Apnea: Researching alternatives to traditional CPAP therapy and managing related cardiovascular risks.

• Pulmonary Hypertension: Investigating treatments to lower blood pressure in the lung’s arteries.

• Alpha-1 Antitrypsin Deficiency: Researching enzyme replacement and genetic therapies for inherited lung conditions.

Common Questions About Respiratory Research:

• Will I have to stop using my current rescue inhaler? Typically, no. Most studies allow you to keep your “as-needed” rescue medication while testing how a new maintenance therapy works alongside it.

• What is a lung function test (Spirometry)? This is a simple, non-invasive test where you breathe into a tube to measure how much air your lungs can hold and how quickly you can exhale. It is a standard part of almost every respiratory study.

In recent years, research has shifted toward Targeted Biologics and Home Monitoring. Depending on the specific trial, researchers may be investigating:

• Biologic Therapies: Using engineered proteins to target the specific type of inflammation (like “Type 2” inflammation) that causes severe asthma or COPD.

• Portable Lung Monitoring: Evaluating how digital spirometers and wearable devices can help patients track their lung health at home in real-time.

• Anti-Fibrotic Innovations: Testing new molecules that can prevent lung tissue from stiffening and losing its ability to transfer oxygen.

• Triple-Combination Therapy: Researching how combining three different types of medications into one inhaler can simplify treatment and improve results.

Eligibility is typically based on your lung function scores, your smoking history, and how often you experience “flares” or exacerbations. General criteria include:

The Screening Process:

Before joining, you will meet with a research team for a screening visit. This ensures the study is a safe and appropriate fit for your specific lung health profile. This visit almost always includes a Pulmonary Function Test (PFT) to establish your baseline breathing capacity.

Respiratory studies provide a structured environment to monitor your breathing and lung health using specialized tools and diagnostic insights not typically available in a standard clinic.

• Informed Consent: The study team explains all details, risks, and benefits before you agree to join.

• Pulmonary Assessments: You will receive regular lung function tests (Spirometry) and vital sign monitoring at no cost.

• Expert Care: Regular visits with board-certified pulmonologists and specialized respiratory therapists.

• Digital Diaries: Many studies provide a handheld device or app for you to record your “peak flow” or daily symptoms.

• No Cost to You: Study-related visits, specialized breathing tests, and investigational inhalers or medications are provided at no cost.

Choosing to participate is a powerful way to access specialized pulmonary care while helping to advance the science of breathing health.

• Access to New Options: Explore investigational inhalers and therapies before they are widely available to the public.

• Expert Pulmonary Monitoring: Receive regular check-ups and in-depth health data from leading lung health specialists.

• No-Cost Respiratory Care: Access specialized breathing tests and medications without the need for insurance.

• Compensation for Time: Most studies provide payment for your time and travel for each visit to the clinic.

• Helping Others Breathe Easier: Your participation provides the data needed to create a future with better treatments for millions of people worldwide.

Your Safety & Privacy

Your physical safety and your privacy are our highest priorities. Every study protocol is reviewed and monitored by an Institutional Review Board (IRB) to ensure it meets the highest ethical and medical standards. Throughout the study, your lung function is closely monitored by a specialized team, and participation is always 100% voluntary.

Breakthroughs in Respiratory Research are occurring every day. Join our patient community to stay updated on upcoming studies and be the first to know when a research opportunity opens in your area.